Trial NCT04480086

View at ClinicalTrials.gov 
Org. Study IDs: M20-248
Secondary IDs: 2020-001226-65

Last trial update was posted on 2023-08-29

MeSH Interventions

Navitoclax

MeSH Conditions

Primary Myelofibrosis

Other Conditions

Myelofibrosis (MF)

Stopping Reasons

Strategic considerations

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID